Friday, 6 December 2013

Novartis aims to show strength with muscle wasting drug


Shareholders queue to enter the St.Jakob Halle for Swiss drug maker Novartis annual general meeting in Basel By Caroline Copley BASEL (Reuters) - Fifteen years ago Ian Parkhill was diagnosed with a rare muscle-wasting disease that gradually robbed him of the strength in his thighs. "The only sort of grip I have is between the thumb and the palm," said 81-year-old Parkhill, a former electrical engineer, who lives in Droitwich, England. I've got to use both hands." Parkhill's rare condition has, to date, gained little attention from drugmakers - but that is starting to change. Big Pharma is focusing a lot more these days on drugs for rare diseases like Parkhill's - and the sky-high prices they can command - and some are also eying the potential of addressing related muscle problems behind a range of more common diseases.








via Health News Headlines - Yahoo! News Read More Here..


Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/12/novartis-aims-to-show-strength-with.html

No comments:

Post a Comment